Ramboll

A life science facility built today needs to be ready for what comes next.

With billions being invested in life science manufacturing across the US, UK and Northern Europe, the decisions made during early planning will shape how well these facilities can adapt in the years ahead.

Changing production needs, growing energy demands, water availability and evolving regulatory requirements can all affect a facility's long-term performance.

As Anders Hummer, Global Life Sciences & Pharma Sector Lead Director at Ramboll, explains: “Future-fit does not mean building everything now. It means understanding which options are difficult to recover later, protecting those, and allowing the rest of the investment to follow the business.”

In our latest news piece, we explore how early decisions around site selection, energy, water, and facility design can help life science manufacturers reduce risks, maintain flexibility, and protect long-term value.

🔗 Read the full news and explore our new guide, Future-proofing your life science site, via the link in the bio.

#LifeSciences #Pharma #SustainableManufacturing